APA (7th ed.) Citation

JR, H., LS, H., AL, S., ME, G., M, T., J, E., . . . RW, S. (2020). Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma. Pediatric blood & cancer, 67(6), e28267. https://doi.org/10.1002/pbc.28267

Chicago Style (17th ed.) Citation

JR, Healy, et al. "Limited Antitumor Activity of Combined BET and MEK Inhibition in Neuroblastoma." Pediatric Blood & Cancer 67, no. 6 (2020): e28267. https://doi.org/10.1002/pbc.28267.

MLA (9th ed.) Citation

JR, Healy, et al. "Limited Antitumor Activity of Combined BET and MEK Inhibition in Neuroblastoma." Pediatric Blood & Cancer, vol. 67, no. 6, 2020, p. e28267, https://doi.org/10.1002/pbc.28267.